Remove 2023 Remove IT Remove Patient-Centered Remove Utilities
article thumbnail

From Crisis to Recovery: Evaluating the Evolution of Patient Care in Academic Medical Centers Through the COVID-19 Era [Big data]

Annals of Family Medicine

Context: The COVID pandemic disrupted global healthcare, impacting Academic Medical Centers (AMCs) in the United States, necessitating a comprehensive understanding of its effects on healthcare delivery and utilization. Study Design: This retrospective case series analysis utilizes Vizient’s clinical database data.

article thumbnail

A New Normal? Assessing Trends and Changes in Inpatient General Medicine During The CO VID-19 Era [Big data]

Annals of Family Medicine

Context: The COVID pandemic disrupted global healthcare, impacting academic medical centers (AMCs) in the United States, necessitating a comprehensive understanding of its effects on healthcare delivery and utilization. Study Design: This retrospective case series analysis utilizes Vizient’s clinical database data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

To Be a Professional: How Family Physicians Interpret and Encounter Professionalism [Qualitative research]

Annals of Family Medicine

Study Design: We analyzed eleven interviews with primary care providers recruited from ABFM diplomates who completed a recertification exam in 2023. Instrument: Interviews were semi-structured and conducted in Summer 2023. Results: Participants conceptualized professionalism as individualized and highly focused on patient care.

article thumbnail

Using technology to reclaim our time

Today's Hospitalist

For many of us, the emergence of medical scribes, both in-person and remote, provided a valuable solution, offloading documentation and allowing us to have more focused patient interactions. At its core, the technology utilizes sophisticated speech recognition to transcribe a conversation in the exam room or at the bedside.

article thumbnail

The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments

FDA Law Blog

When FDA published the fiscal years (FY) 2023-2027 goals letter at the end of August, making known their commitments and planned initiatives for the coming years, we were both excited by many of the announcements, while recognizing the real success will come from how the Agency implements them.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

19:05 Clarifying the “ethics vs science” argument and critiquing research techniques 22:00 Resurgence of race-based speculation in COVID-19-related research 25:57 Implantation of ideas about innate racial inferiority within medicine 28:32 Will removal of race from algorithms potentially harm our patients?

Clinic 52
article thumbnail

Wearables, Sensors, and Apps Part 1 – Updates on FDA’s PDUFA VII Goals for the Use of Digital Health Technologies in Drug and Biological Product Development

FDA Law Blog

This blog provides an update on the DHT-related PDUFA VII goals that were targeted for completion in the first two quarters of FDA’s Fiscal Year (FY) 2023, including: By the end of Q2 FY 2023, FDA will establish a DHT framework document to guide the use of DHT-derived data in regulatory decision-makings for drugs and biological products.